Thalassemia News and Research

Latest Thalassemia News and Research

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

ASH meeting highlights H1N1 pandemic threat, new trends and treatment options for children with genetic blood disorder

New genetic approach may hold promise for sickle cell disease

New genetic approach may hold promise for sickle cell disease

Two abstracts describing preclinical studies with GMI-1070 selected for oral presentations

Two abstracts describing preclinical studies with GMI-1070 selected for oral presentations

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

StemCyte concludes exclusive license and commercialization agreement with Academia Sinica

StemCyte concludes exclusive license and commercialization agreement with Academia Sinica

Therapeutic agents in soy can treat colon cancer, says study

Therapeutic agents in soy can treat colon cancer, says study

Genetix Pharmaceuticals develops a gene therapy product to treat ALD

Genetix Pharmaceuticals develops a gene therapy product to treat ALD

Gene therapy saves two children with adrenoleukodystrophy

Gene therapy saves two children with adrenoleukodystrophy

Interim data from Schering-Plough's narlaprevir Phase IIa study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Progenika to provide blood group genotyping reference laboratory services to ARUP

Progenika to provide blood group genotyping reference laboratory services to ARUP

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough receives FDA recommendation approval for PEGINTRON

Research to develop small-molecule drug that blocks excess iron absorption

Research to develop small-molecule drug that blocks excess iron absorption

Vitamin K prevents age-related conditions

Vitamin K prevents age-related conditions

Olympic gold medalist Shannon Miller to campaign for Stemcyte

Olympic gold medalist Shannon Miller to campaign for Stemcyte

New treatment for vaso-occlusive crisis in sickle cell patients

New treatment for vaso-occlusive crisis in sickle cell patients

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

Children's Hospital Oakland converts to Masimo Rainbow SET Pulse CO-Oximetry technology

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Mother's immune system may block fetal treatments for blood diseases

Mother's immune system may block fetal treatments for blood diseases